Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
=============================================================================================================================================================================================

* Claire F Friedman
* Christine Spencer
* Christopher R Cabanski
* Katherine S Panageas
* Daniel K Wells
* Antoni Ribas
* Hussein Tawbi
* Katy Tsai
* Michael Postow
* Alexander Shoushtari
* Paul Chapman
* Joyson Karakunnel
* Samantha Bucktrout
* Pier Gherardini
* Travis J Hollmann
* Richard O Chen
* Margaret Callahan
* Theresa LaVallee
* Ramy Ibrahim
* Jedd Wolchok